Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial
Huijie Bian(Air Force Medical University), Ye Zhang(Air Force Medical University), Aidong Wen(Xijing Hospital), Na Yao(Air Force Medical University), Ke Dong(China XD Group (China)), Jiejie Geng(Air Force Medical University), Yatao Wang(Air Force Medical University), Jiansheng Zhou(Air Force Medical University), Jianqi Lian(Tang Du Hospital), Fei Huo(Air Force Medical University), Jin Ding(Naval Aerospace Medical Institute), Jielai Xia(Air Force Medical University), Yinan Ma(Air Force Medical University), Yang Zhang(Air Force Medical University), Di Zhang(Xijing Hospital), Zhe Wang(Xijing Hospital), Qing Wang(Nantong University), Kui Zhang(Southwest University), Lijuan Wang(Guangdong Academy of Medical Sciences), Zhe Zhang(Air Force Medical University), Ting Guo(Air Force Medical University), Zheng Zhang(Air Force Medical University), Hong Du(Air Force Medical University), Wen Kang(Air Force Medical University), Qian He(Air Force Medical University), Zhaohui Zheng(Xijing Hospital), Yumeng Zhu(Sichuan University), Ke Wang(Air Force Medical University), Linna Liu(Air Force Medical University), Ying Shi(Air Force Medical University), Zhiqin Li(Xijing Hospital), Guoquan Li(Xijing Hospital), Ruo Chen(Jinan University), Junfeng Jia(Xijing Hospital), Bin Wang(Air Force Medical University), Xiangmin Yang(China XD Group (China)), Jinlin Miao(Xijing Hospital), Xu Yang(Northwest University), Xiuxuan Sun(Air Force Medical University), Rui-Rui Yao(Air Force Medical University), Xie Rong-hua(Xijing Hospital), Wenzhen Kang(Air Force Medical University), Yanyan Jia(Ministry of Education of the People's Republic of China), Chun-Qiu Hao(Air Force Medical University), Jing Wang(Iowa State University), Zhaowei Gao(Air Force Medical University), Xue Liang(Air Force Medical University), Mingru Zhang(Xijing Hospital)
Cited by 66
Related Papers
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial
|The Lancet. Gastroenterology & hepatology|2019|230
Optimal Caliper Width for Propensity Score Matching of Three Treatment Groups: A Monte Carlo Study
|PLoS ONE|2013|201